Basic Information

Gene symbol E2F1 Synonyms E2F-1, RBAP1, RBBP3, RBP3 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description E2F transcription factor 1

GTO ID GTC3979
Trial ID NCT01864759
Disease Melanoma
Altered gene E2F1
Therapeutic/Target gene Therapeutic gene
TherapyDNA oncolytic virus
Treatment ICOVIR5
PhasePhase1
Recruitment statusCompleted
TitlePhase I Clinical Trial of Endovenous Administration of Conditionally Replicative Adenovirus ICOVIR-5 in Patients With Locally Advanced or Metastatic Melanoma
Year2013
CountrySpain
Company sponsorInstitut Català d'Oncologia
Other ID(s)ICOVIR5-2|2008-005694-35
Vector information
Vectoradenovirus
ConstructAd5-E2F-delta24-RGD
Vector typethird-generation retargeted oncolytic adenovirus
Viral genome modificationTo insert the Kozak sequence before E1A, a KpnI fragment from pShuttle-DM-E2F-Δ-24, containing the E2F promoter and E1A, was subcloned into pGEM-3Z (Promega). This plasmid was then used to replace the E1A translation start site with oligonucleotides containing the Kozak sequence. The KpnI fragment, containing the E2F-E1A modified with the Kozak sequence, was returned to pShuttle-DM-E2F-Δ-24 to generate pShuttle-DM-E2F-KD24. Finally, pShuttle-DM-E2F-Δ-24 was recombined by homologous recombination with pVK503, which contains the complete Ad5 genome with an RGD-modified fiber.

Clinical Result

Cohort 1
Administration route intravenous infusion
Dosage 1E11~1E13 vp
Pts 14
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph